As the original provider for a 59‑year‑old woman with sinusitis now on azithromycin who reports antibiotic‑associated diarrhea and has had a C. diff test ordered by another clinician, how should I respond and manage her request for an anti‑diarrheal medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Immediate Response and Management

As the original provider, you should immediately coordinate with the other provider, support the C. diff testing that was ordered, discontinue the azithromycin, and hold off on anti-diarrheal agents until C. diff is ruled out. 1

Your Role and Communication

You need to take ownership of this situation since you initiated the antibiotic therapy. Contact the other provider directly to:

  • Acknowledge that antibiotic-associated diarrhea is a known complication of both the initial antibiotic and azithromycin 2
  • Confirm the C. diff test was appropriately ordered given the clinical context
  • Coordinate a unified management plan to avoid conflicting advice to the patient

Immediate Clinical Actions

1. Stop the Azithromycin Now

Discontinue the inciting antibiotic agent immediately, as continued use decreases clinical response and increases recurrence rates if this is CDI 1. The FDA label explicitly warns that azithromycin can cause C. difficile-associated diarrhea (CDAD), which can range from mild diarrhea to fatal colitis 2.

2. Hold Anti-Diarrheal Medications

Do not prescribe loperamide or other antimotility agents until C. diff is ruled out. Historically, administering antimotility agents to patients with diarrhea without ruling out CDI has led to bad outcomes 1. While adding an antimotility agent as an adjunct to specific CDI therapy may be safe, no prospective studies support this, and the risk of toxic megacolon or fulminant disease is real 1.

3. Assess Disease Severity While Awaiting Results

Obtain or review:

  • White blood cell count: WBC ≥15,000 cells/mL indicates severe disease 1, 3
  • Serum creatinine: Creatinine >1.5 mg/dL (or >1.5× baseline) indicates severe disease 1, 3
  • Clinical signs of fulminant disease: hypotension, shock, ileus, or megacolon 1, 3

This 59-year-old woman with recent antibiotic exposure (two different antibiotics in quick succession) is at increased risk for CDI 4, 5.

Management Based on Test Results

If C. Diff Test is POSITIVE:

First-line treatment is either vancomycin 125 mg orally 4 times daily for 10 days OR fidaxomicin 200 mg twice daily for 10 days 1, 3. Fidaxomicin is preferred due to lower recurrence rates, but vancomycin is acceptable given practical considerations 3.

Do NOT use metronidazole for initial non-severe CDI. The 2018 IDSA/SHEA guidelines downgraded metronidazole to use only in settings where vancomycin or fidaxomicin access is limited, and only for non-severe disease 1. Metronidazole carries risk of cumulative and potentially irreversible neurotoxicity with repeated courses 1.

If C. Diff Test is NEGATIVE:

This is likely simple antibiotic-associated diarrhea (AAD) from microbiome disruption 5, 6. Management includes:

  • Supportive care: hydration, electrolyte replacement
  • Probiotics: While insufficient data exist for CDI prevention, they may help with non-C. diff AAD 1, 6
  • Dietary modifications: encourage fiber-rich foods to restore gut microbiota 3
  • Antimotility agents: NOW safe to use (loperamide) once CDI is excluded 1

Critical Pitfalls to Avoid

  1. Never test for "test of cure" after treatment completion. Only retest if symptoms persist or worsen 3.

  2. Do not repeat C. diff testing within 7 days if initial test is negative but symptoms continue—this leads to false positives from colonization 7, 8.

  3. Recognize azithromycin as a CDI risk factor: Despite its safety profile, azithromycin has been directly linked to C. difficile colitis, especially with repeated courses 4. Your patient received two antibiotic courses in close succession for sinusitis, significantly increasing her risk.

  4. Document the antibiotic stewardship lesson: This case highlights the importance of appropriate antibiotic selection and duration for sinusitis. Consider whether the initial antibiotic was necessary and appropriately chosen 1.

Patient Communication

Explain to the patient:

  • The diarrhea is likely from antibiotic disruption of normal gut bacteria
  • C. diff testing is appropriate and necessary before using anti-diarrheal medications
  • She should stop the azithromycin immediately
  • Results will guide whether she needs specific treatment or just supportive care
  • Emphasize handwashing and home disinfection if C. diff is confirmed 1, 3

Documentation

Document in the medical record:

  • Discontinuation of azithromycin due to antibiotic-associated diarrhea
  • Coordination with the other provider
  • Clinical assessment of severity
  • Plan pending C. diff results
  • Patient education provided

This approach prioritizes patient safety by ruling out potentially life-threatening CDI before symptomatic treatment, while maintaining clear communication between providers.

References

3
Research

AGA Clinical Practice Update on Management of Clostridioides difficile Infection in Adults: Expert Review.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2026

6
Research

Antibiotic-associated diarrhoea.

Expert opinion on drug safety, 2006

Related Questions

In an adult who has taken two doses of azithromycin 500 mg daily for a streptococcal infection and now has more than five loose stools in an eight‑hour period, is antibiotic‑associated diarrhea the most likely cause or should other etiologies such as Clostridioides difficile infection be considered?
What is the appropriate initial therapy for a patient hospitalized in a rehabilitation center who presents to the emergency department with fever and diarrhea and has stool positive for Clostridioides difficile antigen and toxin?
In an 85-year-old nursing home resident with chronic diarrhea and a negative Clostridioides difficile test, what bulk‑forming agent should be used to treat the stool?
As a primary care physician, how should I manage a 59-year-old patient with persistent diarrhea after short courses of amoxicillin‑clavulanate (Augmentin) and azithromycin (Z‑Pack), pending repeat Clostridioides difficile testing?
How should a patient on tirzepatide (Zepbound) be managed when they develop a Clostridioides difficile infection?
What is the interpretation and recommended next steps for a patient with a modestly elevated thyroid‑stimulating hormone (TSH) of 5.26 mIU/L, markedly high thyroxine (T4) of 24 µg/dL, and low‑normal triiodothyronine (T3) of 1.6 ng/mL?
In a 51‑year‑old hypertensive male with serum creatinine 5.4 mg/dL, eGFR 12 mL/min/1.73 m², BUN 31 mg/dL, who is asymptomatic and has no fluid overload, does he require dialysis and should his angiotensin‑II receptor blocker (valsartan) be discontinued?
What is the appropriate management for a patient with an unknown insect bite?
What is the standard neonatal policy for the care of a 24‑week‑gestation infant weighing less than 500 g who shows signs of life?
In a patient with a local insect‑bite reaction, when are oral steroids indicated and what is the appropriate dosing regimen?
What is mesenteric ischemia and which patients are most likely to present with a clinically silent form characterized by unexplained abdominal distension and new organ failure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.